Alpha DNA Investment Management LLC Boosts Stake in The Procter & Gamble Company (NYSE:PG)

Alpha DNA Investment Management LLC raised its position in The Procter & Gamble Company (NYSE:PG) by 101.8% during the third quarter, HoldingsChannel.com reports. The firm owned 11,942 shares of the company’s stock after buying an additional 6,023 shares during the quarter. Procter & Gamble comprises 0.8% of Alpha DNA Investment Management LLC’s investment portfolio, making the stock its 21st biggest position. Alpha DNA Investment Management LLC’s holdings in Procter & Gamble were worth $2,068,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also modified their holdings of the company. Itau Unibanco Holding S.A. acquired a new stake in Procter & Gamble in the 2nd quarter valued at $28,000. Fairway Wealth LLC purchased a new stake in shares of Procter & Gamble in the second quarter worth about $29,000. POM Investment Strategies LLC acquired a new stake in shares of Procter & Gamble in the second quarter valued at about $34,000. Quest Partners LLC purchased a new stake in shares of Procter & Gamble during the 2nd quarter valued at about $36,000. Finally, Fairfield Financial Advisors LTD acquired a new position in Procter & Gamble during the 2nd quarter worth approximately $44,000. 65.77% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Procter & Gamble

In other news, insider Susan Street Whaley sold 634 shares of the stock in a transaction on Wednesday, October 2nd. The stock was sold at an average price of $171.65, for a total value of $108,826.10. Following the completion of the transaction, the insider now owns 19,341 shares of the company’s stock, valued at approximately $3,319,882.65. This represents a 3.17 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, CEO Jon R. Moeller sold 87,979 shares of Procter & Gamble stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $170.40, for a total transaction of $14,991,621.60. Following the sale, the chief executive officer now owns 300,777 shares in the company, valued at approximately $51,252,400.80. This represents a 22.63 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 160,693 shares of company stock worth $27,311,345 in the last ninety days. 0.18% of the stock is owned by insiders.

Procter & Gamble Price Performance

Shares of NYSE:PG opened at $176.28 on Friday. The company has a quick ratio of 0.55, a current ratio of 0.75 and a debt-to-equity ratio of 0.50. The firm has a 50-day simple moving average of $170.04 and a 200 day simple moving average of $168.64. The Procter & Gamble Company has a fifty-two week low of $142.50 and a fifty-two week high of $177.94. The company has a market cap of $415.15 billion, a PE ratio of 30.39, a P/E/G ratio of 3.74 and a beta of 0.42.

Procter & Gamble (NYSE:PG) last announced its quarterly earnings results on Friday, October 18th. The company reported $1.93 earnings per share for the quarter, topping analysts’ consensus estimates of $1.90 by $0.03. The business had revenue of $21.74 billion for the quarter, compared to analysts’ expectations of $21.99 billion. Procter & Gamble had a return on equity of 33.25% and a net margin of 17.07%. The business’s quarterly revenue was down .6% on a year-over-year basis. During the same period in the prior year, the firm earned $1.83 EPS. On average, sell-side analysts anticipate that The Procter & Gamble Company will post 6.94 EPS for the current year.

Procter & Gamble Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Friday, October 18th were issued a $1.0065 dividend. The ex-dividend date of this dividend was Friday, October 18th. This represents a $4.03 dividend on an annualized basis and a dividend yield of 2.28%. Procter & Gamble’s dividend payout ratio (DPR) is presently 69.48%.

Wall Street Analyst Weigh In

PG has been the subject of several recent research reports. Barclays downgraded shares of Procter & Gamble from an “overweight” rating to an “equal weight” rating and set a $163.00 price objective for the company. in a research report on Monday, September 30th. Evercore ISI lifted their price target on shares of Procter & Gamble from $180.00 to $183.00 and gave the stock an “outperform” rating in a research note on Monday, October 21st. Morgan Stanley upped their price objective on shares of Procter & Gamble from $174.00 to $191.00 and gave the company an “overweight” rating in a research report on Monday, October 21st. Dbs Bank downgraded Procter & Gamble from a “strong-buy” rating to a “hold” rating in a research note on Thursday, August 1st. Finally, Hsbc Global Res upgraded Procter & Gamble to a “strong-buy” rating in a research note on Friday, October 4th. Nine research analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $178.00.

Procter & Gamble Profile

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.